225 related articles for article (PubMed ID: 17098845)
1. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease.
Devos D; Krystkowiak P; Clement F; Dujardin K; Cottencin O; Waucquier N; Ajebbar K; Thielemans B; Kroumova M; Duhamel A; Destée A; Bordet R; Defebvre L
J Neurol Neurosurg Psychiatry; 2007 May; 78(5):470-5. PubMed ID: 17098845
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C; Delval A; Defebvre L; Dujardin K; Duhamel A; Petyt G; Vuillaume I; Corvol JC; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Sablonniere B; Azulay JP; Tison F; Rascol O; Vidailhet M; Destée A; Bloem BR; Bordet R; Devos D;
Lancet Neurol; 2012 Jul; 11(7):589-96. PubMed ID: 22658702
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
Espay AJ; Dwivedi AK; Payne M; Gaines L; Vaughan JE; Maddux BN; Slevin JT; Gartner M; Sahay A; Revilla FJ; Duker AP; Shukla R
Neurology; 2011 Apr; 76(14):1256-62. PubMed ID: 21464430
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
6. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study.
Ricchi V; Zibetti M; Angrisano S; Merola A; Arduino N; Artusi CA; Rizzone M; Lopiano L; Lanotte M
Brain Stimul; 2012 Jul; 5(3):388-392. PubMed ID: 21824834
[TBL] [Abstract][Full Text] [Related]
7. Gait and attentional performance in freezers under methylphenidate.
Delval A; Moreau C; Bleuse S; Guehl D; Bestaven E; Guillaud E; Dujardin K; Defebvre L; Devos D
Gait Posture; 2015 Feb; 41(2):384-8. PubMed ID: 25468682
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
Lizarraga KJ; Jagid JR; Luca CC
J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
[TBL] [Abstract][Full Text] [Related]
9. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H
Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730
[TBL] [Abstract][Full Text] [Related]
10. New pharmacological options for treating advanced Parkinson's disease.
Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
[TBL] [Abstract][Full Text] [Related]
11. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic functional connectivity associated with freezing of gait dopa-response.
Lench DH; Doolittle JD; Ramakrishnan V; Rowland N; Revuelta GJ
Parkinsonism Relat Disord; 2024 Jan; 118():105952. PubMed ID: 38101024
[TBL] [Abstract][Full Text] [Related]
13. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
[TBL] [Abstract][Full Text] [Related]
14. Deep brain stimulation effects on gait variability in Parkinson's disease.
Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
[TBL] [Abstract][Full Text] [Related]
15. Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state.
Pollak L; Dobronevsky Y; Prohorov T; Bahunker S; Rabey JM
J Neural Transm Suppl; 2007; (72):145-8. PubMed ID: 17982887
[TBL] [Abstract][Full Text] [Related]
16. Working on asymmetry in Parkinson's disease: randomized, controlled pilot study.
Ricciardi L; Ricciardi D; Lena F; Plotnik M; Petracca M; Barricella S; Bentivoglio AR; Modugno N; Bernabei R; Fasano A
Neurol Sci; 2015 Aug; 36(8):1337-43. PubMed ID: 25677846
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
Devos D; Bordet R; Defebvre L
Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
[TBL] [Abstract][Full Text] [Related]
18. Spinal Cord Stimulation Therapy for Gait Dysfunction in Advanced Parkinson's Disease Patients.
Samotus O; Parrent A; Jog M
Mov Disord; 2018 May; 33(5):783-792. PubMed ID: 29442369
[TBL] [Abstract][Full Text] [Related]
19. Interleaved Stimulation for Freezing of Gait in Advanced Parkinson's Disease.
Zafar SM; Rajan R; Krishnan S; Kesavapisharady K; Kishore A
Neurol India; 2021; 69(2):457-460. PubMed ID: 33904475
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
Devos D; Defebvre L; Bordet R
Fundam Clin Pharmacol; 2010 Aug; 24(4):407-21. PubMed ID: 20163480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
